Increasing HIV-1 pretreatment drug resistance among antiretroviral-naïve adults initiating treatment between 2006 and 2014 in Nairobi, Kenya

AIDS

Volumn 30, Issue 10, 2016, Pages 1680-1682

  Chung, Mich'l H ^a,e   Silverman, Rachel ^a   Beck, Ingrid A ^a   Yatich, Nelly ^a,b   Dross, Sandra ^a   McKernan Mullin, Jennifer ^a   Bii, Stephen ^a   Tapia, Kenneth ^a   Stern, Joshua ^a   Chohan, Bhavna ^a   Sakr, Samah R ^b   Kiarie, James N ^c   Frenkel, Lisa M ^a,d  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Internal Medicine and Critical care Department   (Kenya)

^c UNIVERSITY OF NAIROBI   (Kenya)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; COMPLEMENTARY DNA; LAMIVUDINE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; OLIGONUCLEOTIDE; STAVUDINE; TENOFOVIR; VIRUS DNA;

ADULT; ANTIVIRAL RESISTANCE; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; DNA TEMPLATE; FEMALE; GENE MUTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KENYA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRETREATMENT DRUG RESISTANCE; PREVALENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEXUALITY; DRUG EFFECTS; GENETICS; GENOTYPING TECHNIQUE; HUMAN IMMUNODEFICIENCY VIRUS 1; ISOLATION AND PURIFICATION; MISSENSE MUTATION; VIROLOGY;

ADULT; ANTI-HIV AGENTS; DRUG RESISTANCE, VIRAL; FEMALE; GENOTYPING TECHNIQUES; HIV INFECTIONS; HIV-1; HUMANS; KENYA; MALE; MUTATION, MISSENSE; PREVALENCE;

EID: 84964043750     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000001110     Document Type: Article

References (11)

1. Aghokeng AF, Kouanfack C, Laurent C, Ebong E, Atem-Tambe A, Butel C, et al. Scale-up of antiretroviral treatment in sub- Saharan Africa is accompanied by increasing HIV-1 drug resistance mutations in drug-naive patients. AIDS 2011; 25:2183-2188.
2. Chung MH, Richardson BA, Tapia K, Benki-Nugent S, Kiarie JN, Simoni JM, et al. A randomized controlled trial comparing the effects of counseling and alarmdevice onHAART adherence and virologic outcomes. PLoS Med 2011; 8:e1000422.
3. Chung MH, Drake AL, Richardson BA, Reddy A, Thiga J, Sakr SR, et al. Impact of prior HAART use on clinical outcomes in a large Kenyan HIV treatment program. Curr HIV Res 2009; 7:441-446.
4. Chung MH, Beck IA, Dross S, Tapia K, Kiarie JN, Richardson BA, et al. Oligonucleotide ligation assay detects HIV drug resistance associated with virologic failure among antiretroviralnaive adults in Kenya. J Acquir Immune Defic Syndr 2014; 67:246-253.
5. Micek MA, Blanco AJ, Beck IA, Dross S, Matunha L, Montoya P, et al. Nevirapine resistance by timing of HIV type 1 infection in infants treated with single-dose nevirapine. Clin Infect Dis 2010; 50:1405-1414.
6. Chung MH, Kohler P, Attwa M, Thiga J, John-Stewart GC. Comparing clinic retention between residents and nonresidents of Kibera, Kenya. J Acquir Immune Defic Syndr 2010; 53:422-424.
7. Hamers RL, Wallis CL, Kityo C, Siwale M, Mandaliya K, Conradie F, et al. HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study. Lancet Infect Dis 2011; 11:750-759.
8. HassanAS, MwaringaSM, ObonyoCA, NabweraHM, Sanders EJ, Rinke de Wit TF, et al. Low prevalence of transmitted HIV type 1 drug resistance among antiretroviral-naive adults in a rural HIV clinic in Kenya. AIDS Res Hum Retroviruses 2013; 29:129-135.
9. GuptaRK, JordanMR, Sultan BJ, Hill A, DavisDH, Gregson J, et al. Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis. Lancet 2012; 380:1250-1258.
10. Little SJ, Frost SD, Wong JK, Smith DM, Pond SL, Ignacio CC, et al. Persistence of transmitted drug resistance among subjects with primary human immunodeficiency virus infection. J Virol 2008; 82:5510-5518.
11. Ellis GM, Mahalanabis M, Beck IA, Pepper G, Wright A, Hamilton S, et al. Comparison of oligonucleotide ligation assay and consensus sequencing for detection of drug-resistant mutants of human immunodeficiency virus type 1 in peripheral blood mononuclear cells and plasma. J Clin Microbiol 2004; 42:3670-3674.